Waters's Revenue in the fiscal year 2025 $ 3,165.29 millions
Waters's Revenue in the fiscal year 2024 $ 2,958.39 millions
Waters's Revenue in the fiscal year 2023 $ 2,956.42 millions
Waters's Revenue in the fiscal year 2022 $ 2,971.96 millions
Waters's Revenue in the fiscal year 2021 $ 2,785.87 millions
WAT Revenue third quarter 2026 Y/Y Growth Comment
Waters Corporation achieved in the third quarter 2026, above Company average Revenue surge of 120.91% year on year, to $ 1,767.00 millions.
According to the results reported in the third quarter 2026, Waters Corporation achieved the best Revenue growth in Laboratory Analytical Instruments industry. While Waters Corporation' s Revenue doubling of 120.91% ranks overall at the positon no. 232 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Waters's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
35.89 %
3.28 %
-35.09 %
(Apr 04 2026)
WAT's III. Quarter Q/Q Revenue Comment
Waters Corporation achieved in the III. Quarter 2026 above company average sequential Revenue increase of 7.42%, to $ 1,767.00 millions, from $1,645.00 millions in the second quarter.
Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Waters's Revenue growth quarter on quarter, overall rank is 376.
Waters Corporation achieved in the III. Quarter 2026 above company average sequential Revenue increase of 7.42%, to $ 1,767.00 millions, from $1,645.00 millions in the second quarter.
Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Waters's Revenue growth quarter on quarter, overall rank is 376.
Waters saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 80.68% year on year, to $ 5,611 millions if the fiscal year would have ended in Oct 03 2026. Waters's trailing twelve months Revenue growth was higher than company's average -1% and higher than 52.47% growth in Jul 04 2026. But from twelve months ended Jul 04 2026 rise was beneth at 20.82 % from $4644.25 millions achieved in the period from Jul 04 2026 to Sep 27 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -1%.
In the Healthcare sector 303 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 962 to 1950.
Waters saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 80.68% year on year, to $ 5,611 millions if the fiscal year would have ended in Oct 03 2026. Waters's trailing twelve months Revenue growth was higher than company's average -1% and higher than 52.47% growth in Jul 04 2026. But from twelve months ended Jul 04 2026 rise was beneth at 20.82 % from $4644.25 millions achieved in the period from Jul 04 2026 to Sep 27 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -1%. The momentum is even more impressive from twelve months ended Jul 04 2026 exhibited at 20.82 % increase from $4644.25 millions in the period from Jul 04 2026 to Sep 27 2025.
In the Healthcare sector 303 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 962 to 1950.
Companies with similar Revenue increase for the quarter ending Oct 03 2026 within Healthcare Sector
Y/Y Change %
Revenue for the quarter ending Oct 03 2026
About Waters Revenue Growth Rates (WAT), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
